Japan's Chinese pharmaceutical enterprises expand planting areas and reduce dependence on China

[China Pharmaceutical network industry trends] in order to reduce dependence on China, Tsumura, a large Chinese medicine manufacturer in Japan, will expand the purchase of Chinese herbal medicines as raw materials in Japan Using abandoned primary schools in BAHU City, Qingsen County, northeast Japan, the company launched an empirical test to promote the localization of medicinal ginseng cultivation In Hokkaido, the annual cultivation will increase to 2000 tons by 2021, three times that of 2016 Due to the increasing demand for Chinese herbal medicines and other reasons, the prices of Chinese herbal medicines continue to rise in China, the main place of origin Jincun strives to achieve stable supply by decentralizing production areas, preventing risks of weather and price fluctuations (picture source: Baidu picture) in the empirical experiment, 6 varieties will be cultivated Jincun believes that eight cities are also cool in summer, even without air conditioning to control the temperature, it can also achieve protected cultivation Medicinal ginseng is generally cultivated in the mountains of Northeast China, while Jincun will test whether it can be cultivated on flat land, and discuss to start mass production after 2018 At present, Jincun purchases about 10 kinds of Chinese medicinal materials such as Chuanxiong and Angelica in Hokkaido, which will increase to about 20 kinds in the future The proportion of Chinese herbal medicines purchased by Jincun as a whole is only about 15% at present, and it is expected to increase gradually in the future In addition, the processing base will be strengthened In Kumamoto County, where the main base is located, new facilities will be opened in July in Chaowu Town, etc Jincun will invest about 100 million yen to introduce cleaning and cutting equipment for traditional Chinese medicine into the facility In XiongBen County, the use of traditional Chinese medicine in 2015 was only 22 tons, which will increase to 1.4 times by 2018, reaching 30 tons In China, a major producer, the demand for Chinese herbal medicines for drugs and cosmetics is increasing Prices have soared to about twice the level in 2006 due to unusual weather and speculative hoarding.